title: Klotho inhibits angiotensin II-induced cardiomyocyte hypertrophy through suppression of the AT1R/beta catenin pathway.
abstract: Myocardial hypertrophy is an independent risk factor for cardiac morbidity and mortality. The antiaging protein klotho reportedly possesses a protective role in cardiac diseases. However, the precise mechanisms underlying the cardioprotective effects of klotho remain unknown. This study was aimed to determine the effects of klotho on angiotensin II (Ang II)-induced hypertrophy in neonatal rat cardiomyocytes and the possible mechanism of actions. We found that klotho significantly inhibited Ang II-induced hypertrophic growth of neonatal cardiomyocytes, as evidenced by decreased [(3)H]-Leucine incorporation, cardiomyocyte surface area and β-myosin heavy chain (β-MHC) mRNA expression. Meanwhile, klotho inhibited Ang II-stimulated activation of the Wnt/β-catenin pathway in cardiomyocytes, as evidenced by decreased protein expression of active β-catenin, downregulated protein and mRNA expression of the β-catenin target genes c-myc and cyclin D1, and increased β-catenin phosphorylation. Inhibition of the Wnt/β-catenin pathway by the specific inhibitor XAV939 markedly attenuated Ang II-induced cardiomyocyte hypertrophy. The further study revealed that klotho treatment significantly downregulated protein expression of Ang II receptor type I (AT1R) but not type II (AT2R). The AT1R antagonist losartan inhibited Ang II-stimulated activation of the Wnt/β-catenin pathway and cardiomyocyte hypertrophy. Our findings suggest that klotho inhibits Ang II-induced cardiomyocyte hypertrophy through suppression of the AT1R/β-catenin signaling pathway, which may provide new insights into the mechanism underlying the protective effects of klotho in heart diseases, and raise the possibility that klotho may act as an endogenous antihypertrophic factor by inhibiting the Ang II signaling pathway.
authors.affiliation: Hubei Province Key Laboratory of Cardiovascular, Cerebrovascular, and Metabolic Disorders, Hubei University of Science and Technology, Xianning, 437100, PR China; School of Basic Medicine, Hubei University of Science and Technology, Xianning, 437100, PR China. Electronic address: ylz7210281034@163.com.
authors.forename: Liangzhu
authors.initials: L
authors.lastname: Yu
authors.affiliation: School of Basic Medicine, Hubei University of Science and Technology, Xianning, 437100, PR China.
authors.forename: Wei
authors.initials: W
authors.lastname: Meng
authors.affiliation: School of Basic Medicine, Hubei University of Science and Technology, Xianning, 437100, PR China.
authors.forename: Jieqiong
authors.initials: J
authors.lastname: Ding
authors.affiliation: Hubei Province Key Laboratory of Cardiovascular, Cerebrovascular, and Metabolic Disorders, Hubei University of Science and Technology, Xianning, 437100, PR China.
authors.forename: Menglin
authors.initials: M
authors.lastname: Cheng
mesh_terms: D000804:Angiotensin II / Q000378:metabolism*; D000818:Animals; D006332:Cardiomegaly / Q000378:metabolism* / Q000473:pathology; D002478:Cells, Cultured; D005966:Glucuronidase / Q000378:metabolism*; D000090265:Klotho Proteins; D032383:Myocytes, Cardiac / Q000378:metabolism* / Q000473:pathology; D051381:Rats; D017207:Rats, Sprague-Dawley; D044140:Receptor, Angiotensin, Type 1 / Q000378:metabolism*; D015398:Signal Transduction; D051176:beta Catenin / Q000378:metabolism*
chemical_list: D044140:Receptor, Angiotensin, Type 1; D051176:beta Catenin; D000804:Angiotensin II; D005966:Glucuronidase; D000090265:Klotho Proteins
keywords: Angiotensin II; Cardiomyocyte; Hypertrophy; Klotho; Wnt; β-catenin